Common HIV drug could be used as pre-cancer treatment

4th May 2011

A vaccine which is used to treat HIV can be used to attack the virus which causes cervical cancer, research has found.

The University of Manchester conducted a study which showed that using the drug lopinavir helped to kill cells affected by the human papilloma viruses (HPV), which can lead to cervical cancer, while leaving healthy cells alone.

Researchers also discovered that the vaccine can re-activate an anti-viral system which is suppressed by the HPV virus.

Study author Dr Ian Hampson said: "This is a very significant finding as these cells are not cancer cells but are the closest thing to being like the cells found in a pre-cancerous HPV infection of the cervix."

It has been suggested that around one in six women in the UK is infected with HPVs, which can be transmitted through sexual contact.

Scientists now understand that HPV is the root of all cervical cancer, which is the second most common cancer in women in the UK.

Posted by Jeanette Royston

Hampson, Ian et al. "The HIV protease inhibitor lopinavir up-regulates expression of the antiviral protein ribonuclease L in HPV positive cervical carcinoma cells." Antiviral Therapy. May 2011

Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.

Find a treatment, test or scan available at:


Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.


Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...



© Spire Healthcare Group plc (2016)